Health Policy

Change and growth in our health care system are driven not only by federal and state regulations and legislation but also by private sector entrepreneurs who strive to expand choice, identify new treatments, and develop cures. 

Our Mission

The U.S. Chamber of Commerce's Health Policy Division identifies and advances legislative and regulatory policies to - 

  • Increase access to coverage and services

Scope of Issues

Through the Chamber's ability to convene dynamic groups of stakeholders and engage with our diverse member companies, we drive the dialogue and lead strategic partnerships to accomplish the following: 

 

Advocacy

The Chamber educates and advises member companies about key developments in Washington and collaborates with leaders in Congress and federal agencies to further our policy priorities. 

 

Policy Committees and Working Groups

The Health Policy Division represents our members' views by crafting policy positions through the Employee Benefits Committee (EBC), the Health Care Regulatory Task Force, the Supporting Opioid Solutions (SOS) Task Force, the Health Insurer Council, and the Health Policy Advisory Board. 

 

Recent Activity

EventFeb 16, 2021 - 1:00pm to 2:00pm

Equality of Opportunity in Action: Bridging the Racial Gap for COVID-19 Treatments and Vaccines

The U.S. Chamber of Commerce’s Equality of Opportunity Initiative in partnership with the Chamber’s Discover & Deliver campaign, invites you to Equality of Opportunity in Action: Bridging the Racial Gap for COVID-19 Treatments and Vaccines on Tuesday, February 16 at 1:00 PM EST.

Letters to CongressFeb 02, 2021 - 11:00am

U.S. Chamber Letter on the American Rescue Plan

This Letter was sent to the President of the United States and to the Members of the United States Congress, on the Administration's "American Rescue Plan" and the Chamber's priorities for a bipartisan COVID-19 relief package.

Letters to CongressJan 15, 2021 - 9:15am

U.S. Chamber Letter on the Nomination of Alejandro Mayorkas to be Secretary of the Department of Homeland Security

This Hill Letter was sent to the Senate Committee on Homeland Security and Governmental Affairs, on the nomination of Alejandro Mayorkas to be Secretary of the Department of Homeland Security.

Above the FoldJan 08, 2021 - 10:00am
General Paul Ostrowski, director of supply, production and distribution for Operation Warp Speed.

The Path Forward: Operation Warp Speed Leader Sees Vaccine Distribution for Essential Workers, Elderly Starting Next Week

The latest on Operation Warp Speed from General Paul Ostrowski, director of supply, production and distribution for the program.

Press ReleaseDec 11, 2020 - 9:45pm

U.S. Chamber Applauds the Emergency Use Authorization of Pfizer’s Pandemic Vaccine

WASHINGTON, D.C. - U.S. Chamber of Commerce President Suzanne P. Clark today released the following statement regarding the Food and Drug Administration decision to grant an Emergency Use Authorization for Pfizer and BioNTech’s COVID-19 vaccine: 

Press ReleaseNov 20, 2020 - 3:00pm

U.S. Chamber: Most Favored Nation Drug Pricing Harms American Innovation and Investment in New Medicines

The U.S. Chamber will challenge this flawed and harmful policy

Above the FoldSep 08, 2020 - 12:30pm
Healthcare

Washington State Public Option Fails to Deliver Savings to Consumers

Our VP of Health Policy explains why Congress should strengthen employer-sponsored insurance rather than a create a public option.

EventAug 13, 2020 - 1:30pm to 2:30pm
Health Care Event Teaser Graphic

Strengthening Coverage: The Future of Employer-Sponsored Insurance

Please join us for a discussion with business and policy leaders from across the country on the evolution of the employer-sponsored insurance (ESI) market and the future of this important coverage option for 180 million Americans. During the event we will unveil new research insights into the impact of a public option or Medicare buy-in on employees’ coverage.

ReportAug 13, 2020 - 9:00am
Cover of the Report "The Negative Economic Effects of Medicare for All and Medicare Buy-In Proposals"

The Negative Economic Effects of Medicare for All and Medicare Buy-In Proposals

This paper discusses recent proposals to expand Medicare and lays out the likely impact such a move would have on various stakeholders. For the sake of simplicity, this paper discusses Medicare for all and Medicare buy-in proposals, but the points apply more broadly.

Above the FoldJul 24, 2020 - 12:45pm
COVID-19 clinical trials

U.S. Innovators Taking Friendly Fire in the Pandemic Fight

The U.S. bio-pharmaceutical sector is committed to fighting COVID-19, but imposing artificial price controls could impede progress.